Neonc Technologies Holdings, Inc. (NTHI): Total Liabilities
$20.33M
As of 2025-12-31
$23.76M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $20.33M | +127.9% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $8.92M | n/a | 2026-03-31, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $20.33M | +127.9% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $55.04M | +248.4% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $91.85M | -15.0% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $1.85M | -85.8% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $21.76M | -41.2% |
| Talphera, Inc. (TLPH) | 2025-12-31 | $12.68M | +23.9% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $33.41M | +88.8% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $14.10M | +54.6% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $50.21M | +12.4% |
Compare NTHI, ALT, LYEL, IBO side by side · Screen every company in Pharmaceutical Preparations ↗